首页 > 最新文献

Scandinavian Cardiovascular Journal最新文献

英文 中文
A comparison of risk scores’ long-term predictive abilities for patients diagnosed with ST elevation myocardial infarction who underwent early percutaneous coronary intervention 早期经皮冠状动脉介入治疗ST段抬高型心肌梗死患者的风险评分长期预测能力比较
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2066718
A. Aldujeli, A. Haq, A. Hamadeh, Auguste Stalmokaite, Laurynas Maciulevicius, Egle Labanauskaite, I. Navickaitė, Z. Kurnickaite, G. Jaruševičius, R. Unikas, D. Zaliaduonytė, K. Tecson
Abstract Objective. To compare the long-term (5 year) prognostic values of commonly used risk scores on major adverse cardiovascular events (MACE) in a cohort of patients who underwent primary PCI for STEMI. Design. We created a composite endpoint of MACE, defined as the occurrence of any of the following events within 5 years: ischemic or hemorrhagic stroke, target vessel revascularization, nonfatal myocardial infarction, cardiovascular death. We dichotomized risk scores into high risk and not high risk according to the literature’s pre-existing cutoffs as follows: GRACE score >127 = high risk, SYNTAX I score ≥33 = high risk, SYNTAX II ≥32 high risk, TIMI >8 = high risk. We utilized the area under the receiver operating characteristic curve (AUC) as the metric for predictive ability. Results. There were 768 patients in this study and 416 (54.2%), 209 (27.2%), 511 (66.5%), and 74 (9.6%) were at high risk according to the GRACE, SYNTAX I, SYNTAX II, and TIMI scores, respectively. The AUCs for 5-year MACE were 0.54 (95% confidence interval (CI): 0.49–0.59, p = .0947), 0.79 (95% CI: 0.75–0.83, p < .0001), 0.58 (95% CI: 0.54–0.62, p = .0004), and 0.5 (95% CI: 0.48–0.53, p = .7259), respectively. Conclusion. SYNTAX I score was superior in predicting MACE in patients with STEMI and a high burden of CAD. Utilizing the basal SYNTAX I score in STEMI patients with significant non-culprit CAD may improve risk stratification, decision-making, and outcomes.
摘要目的。比较STEMI患者接受初级PCI治疗的主要不良心血管事件(MACE)常用风险评分的长期(5年)预后价值。设计。我们创建了MACE的复合终点,定义为5年内发生以下任何事件:缺血性或出血性卒中、靶血管重建术、非致死性心肌梗死、心血管死亡。我们根据文献已有截止值将风险评分分为高风险和非高风险:GRACE评分>127 =高风险,SYNTAX I评分≥33 =高风险,SYNTAX II评分≥32 =高风险,TIMI评分>8 =高风险。我们利用接收者工作特征曲线下的面积(AUC)作为预测能力的度量。结果。本研究共有768例患者,根据GRACE、SYNTAX I、SYNTAX II和TIMI评分,分别有416例(54.2%)、209例(27.2%)、511例(66.5%)和74例(9.6%)为高危患者。5年MACE的auc分别为0.54(95%可信区间(CI): 0.49-0.59, p = 0.947)、0.79 (95% CI: 0.75-0.83, p < 0.0001)、0.58 (95% CI: 0.54 - 0.62, p = 0.0004)和0.5 (95% CI: 0.48-0.53, p = 0.7259)。结论。SYNTAX I评分在预测STEMI和高CAD负担患者的MACE方面具有优势。在STEMI患者中使用基础SYNTAX I评分可以改善风险分层、决策和结果。
{"title":"A comparison of risk scores’ long-term predictive abilities for patients diagnosed with ST elevation myocardial infarction who underwent early percutaneous coronary intervention","authors":"A. Aldujeli, A. Haq, A. Hamadeh, Auguste Stalmokaite, Laurynas Maciulevicius, Egle Labanauskaite, I. Navickaitė, Z. Kurnickaite, G. Jaruševičius, R. Unikas, D. Zaliaduonytė, K. Tecson","doi":"10.1080/14017431.2022.2066718","DOIUrl":"https://doi.org/10.1080/14017431.2022.2066718","url":null,"abstract":"Abstract Objective. To compare the long-term (5 year) prognostic values of commonly used risk scores on major adverse cardiovascular events (MACE) in a cohort of patients who underwent primary PCI for STEMI. Design. We created a composite endpoint of MACE, defined as the occurrence of any of the following events within 5 years: ischemic or hemorrhagic stroke, target vessel revascularization, nonfatal myocardial infarction, cardiovascular death. We dichotomized risk scores into high risk and not high risk according to the literature’s pre-existing cutoffs as follows: GRACE score >127 = high risk, SYNTAX I score ≥33 = high risk, SYNTAX II ≥32 high risk, TIMI >8 = high risk. We utilized the area under the receiver operating characteristic curve (AUC) as the metric for predictive ability. Results. There were 768 patients in this study and 416 (54.2%), 209 (27.2%), 511 (66.5%), and 74 (9.6%) were at high risk according to the GRACE, SYNTAX I, SYNTAX II, and TIMI scores, respectively. The AUCs for 5-year MACE were 0.54 (95% confidence interval (CI): 0.49–0.59, p = .0947), 0.79 (95% CI: 0.75–0.83, p < .0001), 0.58 (95% CI: 0.54–0.62, p = .0004), and 0.5 (95% CI: 0.48–0.53, p = .7259), respectively. Conclusion. SYNTAX I score was superior in predicting MACE in patients with STEMI and a high burden of CAD. Utilizing the basal SYNTAX I score in STEMI patients with significant non-culprit CAD may improve risk stratification, decision-making, and outcomes.","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44095993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of postoperative atrial fibrillation with postoperative epicardial electrograms. 术后心外膜电图预测心房颤动。
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2130421
Louise Feilberg Rasmussen, Jan Jesper Andreasen, Sam Riahi, Gregory Y H Lip, Søren Lundbye-Christensen, Jacob Melgaard, Claus Graff

Objectives. New-onset postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery. The arrhythmia often entails a longer hospital stay, greater risk of other complications, and higher mortality both short- and long-term. An investigation of the use of early atrial electrograms in predicting POAF in cardiac surgery was performed. Design. In this prospective observational study, a total of 99 consecutive adult patients undergoing coronary artery bypass grafting, valve surgery or both were included. On the first postoperative morning, standard 12-lead electrograms (ECG), unipolar atrial electrograms (aEG), and vital values were recorded. The outcome was new-onset POAF within one month postoperatively. Results. Three multivariable prediction models for POAF were formed using measurements derived from the ECG, aEG, and patient characteristics. Age, body mass index, and two unipolar electrogram measurements quantifying local activation time and fractionation were strongly associated with the outcome POAF. The performance of the POAF prediction models was assessed through receiver operating curve characteristics with cross-validation, and discrimination using the leave-one-out-method to internally validate the models. The cross-validated area under the receiver operating characteristic curve (AUC) was improved in a prediction model using atrial-derived electrogram variables (AUC 0.796, 95% CI 0.698-0.894), compared with previous ECG and clinical models (AUC 0.716, 95% CI 0.606-0.826 and AUC 0.718, 95% CI 0.613-0.822, respectively). Conclusions. This study found that easily obtainable measurements from atrial electrograms may be helpful in identifying patients at risk of POAF in cardiac surgery.

目标。术后新发心房颤动(POAF)是心脏手术后常见的并发症。心律失常通常需要更长的住院时间,更大的其他并发症风险,以及更高的短期和长期死亡率。研究早期心房电图在心脏手术中预测POAF的应用。设计。在这项前瞻性观察性研究中,共纳入99例连续接受冠状动脉搭桥术、瓣膜手术或两者同时进行的成人患者。术后第一天上午,记录标准12导联心电图(ECG)、单极心房电图(aEG)及生命体征。结果为术后1个月内新发POAF。结果。利用ECG、aEG和患者特征的测量数据,形成了POAF的三个多变量预测模型。年龄、体重指数和量化局部激活时间和分异的两个单极电图测量与结果POAF密切相关。通过交叉验证的受试者工作曲线特征来评估POAF预测模型的性能,并使用留一法对模型进行内部验证。与之前的心电图和临床模型(AUC分别为0.716,95% CI 0.606-0.826, AUC 0.718, 95% CI 0.613-0.822)相比,采用心房源性电图变量的预测模型(AUC 0.796, 95% CI 0.698-0.894)改善了受试者工作特征曲线下的交叉验证面积(AUC 0.796, 95% CI 0.698-0.894)。结论。这项研究发现,容易获得的心房电图测量可能有助于识别心脏手术中有POAF风险的患者。
{"title":"Prediction of postoperative atrial fibrillation with postoperative epicardial electrograms.","authors":"Louise Feilberg Rasmussen,&nbsp;Jan Jesper Andreasen,&nbsp;Sam Riahi,&nbsp;Gregory Y H Lip,&nbsp;Søren Lundbye-Christensen,&nbsp;Jacob Melgaard,&nbsp;Claus Graff","doi":"10.1080/14017431.2022.2130421","DOIUrl":"https://doi.org/10.1080/14017431.2022.2130421","url":null,"abstract":"<p><p><i>Objectives.</i> New-onset postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery. The arrhythmia often entails a longer hospital stay, greater risk of other complications, and higher mortality both short- and long-term. An investigation of the use of early atrial electrograms in predicting POAF in cardiac surgery was performed. <i>Design.</i> In this prospective observational study, a total of 99 consecutive adult patients undergoing coronary artery bypass grafting, valve surgery or both were included. On the first postoperative morning, standard 12-lead electrograms (ECG), unipolar atrial electrograms (aEG), and vital values were recorded. The outcome was new-onset POAF within one month postoperatively. <i>Results.</i> Three multivariable prediction models for POAF were formed using measurements derived from the ECG, aEG, and patient characteristics. Age, body mass index, and two unipolar electrogram measurements quantifying local activation time and fractionation were strongly associated with the outcome POAF. The performance of the POAF prediction models was assessed through receiver operating curve characteristics with cross-validation, and discrimination using the leave-one-out-method to internally validate the models. The cross-validated area under the receiver operating characteristic curve (AUC) was improved in a prediction model using atrial-derived electrogram variables (AUC 0.796, 95% CI 0.698-0.894), compared with previous ECG and clinical models (AUC 0.716, 95% CI 0.606-0.826 and AUC 0.718, 95% CI 0.613-0.822, respectively). <i>Conclusions.</i> This study found that easily obtainable measurements from atrial electrograms may be helpful in identifying patients at risk of POAF in cardiac surgery.</p>","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10412104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Echocardiographic diagnosis of heart failure with preserved ejection fraction in elderly patients with hypertension. 老年高血压患者保留射血分数心衰的超声心动图诊断。
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2129777
Magnus C Johansson, Annika Rosengren, Michael Fu

Objectives. The aim of this study is to evaluate the diagnostic performance of echocardiography for the diagnosis of heart failure with preserved ejection fraction (HFpEF) in the elderly and to validate the Heart Failure Association diagnostic algorithm (HFA-PEFF). Design. A case-control study was conducted in patients with hypertension with or without HFpEF who were matched for age (n = 33; 78.4 ± 5.3 years) and sex. Participants underwent echocardiography including assessment of left atrial (LA) volume index (LAVI), early mitral filling to early diastolic mitral annulus velocity ratio (E/e'), LA reservoir strain (LASr), tissue Doppler LA contraction (a'), right ventricular isovolumic relaxation time (RVIVRT), and a 6-minute walk test (6-MWT). The filling pressure algorithm from the European association of cardiovascular imaging (EACVI) 2021 was applied. The HFA-PEFF score was also applied, using echocardiography parameters and the value of NT pro-BNP, without considering symptomatic status. Results. Echocardiographic parameters identified patients with HFpEF with an area under the curve (AUC) >0.9 for E/e', RVIVRT, LASr, a', and the ratio of LAVI/a'. LASr correlated with 6-MWT (r = 0.59, p = .0003). The EACVI algorithm classified all controls with normal filling pressure and 94% of patients with HFpEF with increased filling pressure. When the HFA-PEFF diagnostic algorithm was validated, a high score (≥5 points) had 100% sensitivity for HFpEF, while 88% of controls had intermediate scores (2-4 points). Conclusion. The EACVI filling pressure algorithm, RVIVRT, LASr, and the ratio LAVI/a' were accurate for diagnosing HFpEF in elderly patients with hypertension. The HFA-PEFF score had high sensitivity but limited ability to exclude HFpEF.

目标。本研究的目的是评估超声心动图对老年人保留射血分数心力衰竭(HFpEF)的诊断性能,并验证心力衰竭关联诊断算法(HFA-PEFF)的有效性。设计。在伴有或不伴有HFpEF的高血压患者中进行了一项病例对照研究,这些患者的年龄相匹配(n = 33;78.4±5.3岁)和性别。参与者接受超声心动图检查,包括评估左心房(LA)容积指数(LAVI)、早期二尖瓣充盈至舒张早期二尖瓣环速度比(E/ E’)、LA储层应变(LASr)、组织多普勒LA收缩(a’)、右心室等容松弛时间(RVIVRT)和6分钟步行试验(6-MWT)。采用欧洲心血管成像协会(EACVI) 2021年的填充压力算法。应用HFA-PEFF评分,采用超声心动图参数和NT pro-BNP值,不考虑症状状态。结果。超声心动图参数E/ E′、RVIVRT、LASr、a′和LAVI/a′比值曲线下面积(AUC) >0.9的HFpEF患者。LASr与6-MWT相关(r = 0.59, p = 0.0003)。EACVI算法将所有正常填充压力的对照组和94%填充压力增加的HFpEF患者分类。当HFA-PEFF诊断算法被验证时,高评分(≥5分)对HFpEF的敏感性为100%,而88%的对照组为中等评分(2-4分)。结论。EACVI充盈压力算法、RVIVRT、LASr、LAVI/a’比值对老年高血压患者HFpEF诊断准确。HFA-PEFF评分具有较高的敏感性,但排除HFpEF的能力有限。
{"title":"Echocardiographic diagnosis of heart failure with preserved ejection fraction in elderly patients with hypertension.","authors":"Magnus C Johansson,&nbsp;Annika Rosengren,&nbsp;Michael Fu","doi":"10.1080/14017431.2022.2129777","DOIUrl":"https://doi.org/10.1080/14017431.2022.2129777","url":null,"abstract":"<p><p><i>Objectives</i>. The aim of this study is to evaluate the diagnostic performance of echocardiography for the diagnosis of heart failure with preserved ejection fraction (HFpEF) in the elderly and to validate the Heart Failure Association diagnostic algorithm (HFA-PEFF). <i>Design.</i> A case-control study was conducted in patients with hypertension with or without HFpEF who were matched for age (<i>n</i> = 33; 78.4 ± 5.3 years) and sex. Participants underwent echocardiography including assessment of left atrial (LA) volume index (LAVI), early mitral filling to early diastolic mitral annulus velocity ratio (<i>E</i>/<i>e</i>'), LA reservoir strain (LASr), tissue Doppler LA contraction (<i>a</i>'), right ventricular isovolumic relaxation time (RVIVRT), and a 6-minute walk test (6-MWT). The filling pressure algorithm from the European association of cardiovascular imaging (EACVI) 2021 was applied. The HFA-PEFF score was also applied, using echocardiography parameters and the value of NT pro-BNP, without considering symptomatic status. <i>Results.</i> Echocardiographic parameters identified patients with HFpEF with an area under the curve (AUC) >0.9 for <i>E</i>/<i>e</i>', RVIVRT, LASr, <i>a</i>', and the ratio of LAVI/<i>a</i>'. LASr correlated with 6-MWT (<i>r</i> = 0.59, <i>p</i> = .0003). The EACVI algorithm classified all controls with normal filling pressure and 94% of patients with HFpEF with increased filling pressure. When the HFA-PEFF diagnostic algorithm was validated, a high score (≥5 points) had 100% sensitivity for HFpEF, while 88% of controls had intermediate scores (2-4 points). <i>Conclusion</i>. The EACVI filling pressure algorithm, RVIVRT, LASr, and the ratio LAVI/<i>a</i>' were accurate for diagnosing HFpEF in elderly patients with hypertension. The HFA-PEFF score had high sensitivity but limited ability to exclude HFpEF.</p>","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10760646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hemodynamic changes during aortic valve surgery among patients with aortic stenosis. 主动脉瓣狭窄患者主动脉瓣手术期间血流动力学的变化。
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2099008
Rasmus Carter-Storch, Søren Mose Hansen, Jordi S Dahl, Kasper Enevold, Nils Sofus Borg Mogensen, Henrik Berg, Marie-Annick Clavel, Jacob E Møller

Introduction. Patients with severe aortic stenosis (AS) undergoing surgery are at increased risk of hypotension and hypoperfusion. Although treatable with inotropic agents or fluid, little is known about how these therapies affect central hemodynamics in AS patients under general anesthesia. We measured changes in central hemodynamics after dobutamine infusion and fluid bolus among patients with severe AS and associated these changes with preoperative echocardiography. Methods. We included 33 patients with severe AS undergoing surgical AVR. After induction of general anesthesia, hemodynamic measurements were obtained with a pulmonary artery catheter, including Cardiac index (CI), stroke volume index (SVi) and pulmonary capillary wedge pressure (PCWP). Measurements were repeated during dobutamine infusion, after fluid bolus and lastly after sternotomy. Results. General anesthesia resulted in a decrease in CI and SVi compared to preoperative values. During dobutamine infusion CI increased but mean SVi did not (38 ± 12 vs 37 ± 13 ml/m2, p = .90). Higher EF and SVi before surgery and a larger decrease in SVi after induction of general anesthesia were associated with an increase in SVi during dobutamine infusion. After fluid bolus both CI, SVi (48 ± 12 vs 37 ± 13 ml/min/m2, p < .0001) and PCWP increased. PCWP increased mostly among patients with a larger LA volume index. Conclusion. In patients with AS, CI can be increased with both dobutamine and fluid during surgery. Dobutamine's effect on SVI was highly variable and associated with baseline LVEF, and an increase in CI was mostly driven by an increase in heart rate. Fluid increased SVi at the cost of an increase in PCWP.

介绍。严重主动脉瓣狭窄(AS)患者接受手术时低血压和灌注不足的风险增加。虽然可以用肌力药物或液体治疗,但对于这些疗法如何影响全身麻醉下AS患者的中枢血流动力学知之甚少。我们测量了严重AS患者在多巴酚丁胺输注和输液后中枢血流动力学的变化,并将这些变化与术前超声心动图相关联。方法。我们纳入了33例接受外科AVR治疗的严重AS患者。全麻诱导后,通过肺动脉导管进行血流动力学测量,包括心脏指数(CI)、脑卒中容积指数(SVi)和肺毛细血管楔压(PCWP)。在多巴酚丁胺输注期间,在液体丸后和最后在胸骨切开后重复测量。结果。与术前相比,全身麻醉导致CI和SVi下降。多巴酚丁胺输注时CI升高,但平均SVi没有升高(38±12 vs 37±13 ml/m2, p = 0.90)。术前较高的EF和SVi以及全麻诱导后SVi的较大下降与多巴酚丁胺输注期间SVi的增加有关。注液后CI、SVi分别为48±12 vs 37±13 ml/min/m2, p。在AS患者中,术中多巴酚丁胺和液体均可增加CI。多巴酚丁胺对SVI的影响是高度可变的,与基线LVEF有关,CI的增加主要是由心率的增加引起的。流体增加SVi的代价是增加PCWP。
{"title":"Hemodynamic changes during aortic valve surgery among patients with aortic stenosis.","authors":"Rasmus Carter-Storch,&nbsp;Søren Mose Hansen,&nbsp;Jordi S Dahl,&nbsp;Kasper Enevold,&nbsp;Nils Sofus Borg Mogensen,&nbsp;Henrik Berg,&nbsp;Marie-Annick Clavel,&nbsp;Jacob E Møller","doi":"10.1080/14017431.2022.2099008","DOIUrl":"https://doi.org/10.1080/14017431.2022.2099008","url":null,"abstract":"<p><p><i>Introduction.</i> Patients with severe aortic stenosis (AS) undergoing surgery are at increased risk of hypotension and hypoperfusion. Although treatable with inotropic agents or fluid, little is known about how these therapies affect central hemodynamics in AS patients under general anesthesia. We measured changes in central hemodynamics after dobutamine infusion and fluid bolus among patients with severe AS and associated these changes with preoperative echocardiography. <i>Methods.</i> We included 33 patients with severe AS undergoing surgical AVR. After induction of general anesthesia, hemodynamic measurements were obtained with a pulmonary artery catheter, including Cardiac index (CI), stroke volume index (SVi) and pulmonary capillary wedge pressure (PCWP). Measurements were repeated during dobutamine infusion, after fluid bolus and lastly after sternotomy. <i>Results.</i> General anesthesia resulted in a decrease in CI and SVi compared to preoperative values. During dobutamine infusion CI increased but mean SVi did not (38 ± 12 vs 37 ± 13 ml/m<sup>2</sup>, <i>p</i> = .90). Higher EF and SVi before surgery and a larger decrease in SVi after induction of general anesthesia were associated with an increase in SVi during dobutamine infusion. After fluid bolus both CI, SVi (48 ± 12 vs 37 ± 13 ml/min/m<sup>2</sup>, <i>p</i> < .0001) and PCWP increased. PCWP increased mostly among patients with a larger LA volume index. <i>Conclusion.</i> In patients with AS, CI can be increased with both dobutamine and fluid during surgery. Dobutamine's effect on SVI was highly variable and associated with baseline LVEF, and an increase in CI was mostly driven by an increase in heart rate. Fluid increased SVi at the cost of an increase in PCWP.</p>","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40601832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnosis and treatment of the rare procedural complication of malpositioned pacing leads in the left heart: a single center experience. 左心起搏导联错位罕见手术并发症的诊断与治疗:单中心经验。
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2099013
Rasmus Borgquist, Maiwand Farouq, Hanna Markstad, Johan Brandt, David Mörtsell, Steen Jensen, Uzma Chaudhry, Lingwei Wang

Objectives. This study assessed the management approach and outcome of the pacemaker or implantable cardioverter-defibrillator (ICD) leads malpositioned in the left heart. Malpositioned leads (MPLs) may have deleterious consequences, and appropriate management remains uncertain. Methods. The study population included all patients referred to a single institution for MPL in the left side of the heart after pacemaker or ICD implantation during the period from 2015 to 2021. The approach and outcome of lead management were retrospectively assessed. Results. During the study period, 6887 patients underwent device implantation. MPL was diagnosed in five patients (0.07%). In four cases, the pacing lead was placed in a coronary sinus (CS) branch, while the pacing lead was inside the left ventricle (LV) in one case. Symptoms suggestive of lead malposition were reported by 2 patients (40%). One of the patients presented with recurrent TIAs. Another presented with inappropriate ICD shocks. In one asymptomatic case, an ICD lead changed position from the right ventricle to the CS, suggesting idiopathic lead migration. In 4/5 patients, the leads were removed or repositioned by percutaneous approach, with no major periprocedural complications. Conclusions. In this series of MPL in the left heart, two patients presented with thromboembolic events or inappropriate ICD shocks. These serious complications highlight the critical need for early correct diagnosis and proper management of MPL.

目标。本研究评估了起搏器或植入式心律转复除颤器(ICD)导联在左心错位的处理方法和结果。定位不当的线索(MPLs)可能会产生有害的后果,适当的管理仍然不确定。方法。研究人群包括2015年至2021年期间在起搏器或ICD植入后到单一机构进行左侧心脏MPL的所有患者。回顾性评估铅管理的方法和结果。结果。在研究期间,6887名患者接受了器械植入。确诊MPL 5例(0.07%)。4例起搏导联放置在冠状窦(CS)分支,1例起搏导联放置在左心室(LV)内。2例患者(40%)报告了提示铅定位异常的症状。1例患者出现复发性tia。另一人出现不适当的ICD电击。在一个无症状的病例中,ICD导联从右心室改变位置到CS,提示特发性铅迁移。4/5的患者通过经皮入路将导线取出或重新定位,无重大围手术期并发症。结论。在这一系列左心MPL中,两名患者出现血栓栓塞事件或不适当的ICD电击。这些严重的并发症突出了早期正确诊断和适当治疗MPL的迫切需要。
{"title":"Diagnosis and treatment of the rare procedural complication of malpositioned pacing leads in the left heart: a single center experience.","authors":"Rasmus Borgquist,&nbsp;Maiwand Farouq,&nbsp;Hanna Markstad,&nbsp;Johan Brandt,&nbsp;David Mörtsell,&nbsp;Steen Jensen,&nbsp;Uzma Chaudhry,&nbsp;Lingwei Wang","doi":"10.1080/14017431.2022.2099013","DOIUrl":"https://doi.org/10.1080/14017431.2022.2099013","url":null,"abstract":"<p><p><i>Objectives</i>. This study assessed the management approach and outcome of the pacemaker or implantable cardioverter-defibrillator (ICD) leads malpositioned in the left heart. Malpositioned leads (MPLs) may have deleterious consequences, and appropriate management remains uncertain. <i>Methods</i>. The study population included all patients referred to a single institution for MPL in the left side of the heart after pacemaker or ICD implantation during the period from 2015 to 2021. The approach and outcome of lead management were retrospectively assessed. <i>Results</i>. During the study period, 6887 patients underwent device implantation. MPL was diagnosed in five patients (0.07%). In four cases, the pacing lead was placed in a coronary sinus (CS) branch, while the pacing lead was inside the left ventricle (LV) in one case. Symptoms suggestive of lead malposition were reported by 2 patients (40%). One of the patients presented with recurrent TIAs. Another presented with inappropriate ICD shocks. In one asymptomatic case, an ICD lead changed position from the right ventricle to the CS, suggesting idiopathic lead migration. In 4/5 patients, the leads were removed or repositioned by percutaneous approach, with no major periprocedural complications. <i>Conclusions</i>. In this series of MPL in the left heart, two patients presented with thromboembolic events or inappropriate ICD shocks. These serious complications highlight the critical need for early correct diagnosis and proper management of MPL.</p>","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40635502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The relationship between six-minute walked distance and health-related quality of life in patients with chronic heart failure. 慢性心力衰竭患者6分钟步行距离与健康相关生活质量的关系
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2107234
Charlotta Lans, Åsa Cider, Eva Nylander, Lars Brudin

Objectives. To assess the relationship between the six-minute walk test (6MWT) and health-related quality of life (HRQL) in patients with chronic heart failure. Methods. Forty-six patients (37 men and 9 women) with chronic heart failure, mean age 68 (SD 9), NYHA II-III and EF 29 (9) % were included. They performed 6MWT and assessed HRQL using two tools, a Swedish version of the 36-item Short Form (SF-36) and the Minnesota Living with Heart Failure Questionnaire (MLHFQ). This was performed repeatedly during a study period of one year. Results. Patients with a walking distance lower than median experienced a lower HRQL than the higher performing half of the cohort, in four dimensions of the SF-36 and the summary of physical and mental components, but not in the dimensions of MLHFQ. Conclusion. Patients with heart failure with a short walking distance assessed their quality of life as inferior in half of the dimensions in the SF-36 but not in the dimensions measured with the MLHFQ. Thus, different aspects of the symptomatology are uncovered using the 6MWT and the different HRQL tools.

目标。评估慢性心力衰竭患者6分钟步行试验(6MWT)与健康相关生活质量(HRQL)之间的关系。方法。纳入46例慢性心力衰竭患者(男37例,女9例),平均年龄68岁(SD 9), NYHA II-III和EF 29(9) %。他们使用两种工具进行6MWT和HRQL评估,一种是瑞典版的36项短表(SF-36)和明尼苏达州心力衰竭生活问卷(MLHFQ)。这项研究在一年的研究期间反复进行。结果。步行距离低于中位数的患者的HRQL在SF-36的四个维度和身心成分的总结中低于表现较好的那一半患者,但在MLHFQ的维度中没有。结论。步行距离短的心力衰竭患者在SF-36的一半维度中评估其生活质量较差,但在MLHFQ测量的维度中并非如此。因此,使用6MWT和不同的HRQL工具可以揭示症状学的不同方面。
{"title":"The relationship between six-minute walked distance and health-related quality of life in patients with chronic heart failure.","authors":"Charlotta Lans,&nbsp;Åsa Cider,&nbsp;Eva Nylander,&nbsp;Lars Brudin","doi":"10.1080/14017431.2022.2107234","DOIUrl":"https://doi.org/10.1080/14017431.2022.2107234","url":null,"abstract":"<p><p><i>Objectives</i>. To assess the relationship between the six-minute walk test (6MWT) and health-related quality of life (HRQL) in patients with chronic heart failure. <i>Methods</i>. Forty-six patients (37 men and 9 women) with chronic heart failure, mean age 68 (SD 9), NYHA II-III and EF 29 (9) % were included. They performed 6MWT and assessed HRQL using two tools, a Swedish version of the 36-item Short Form (SF-36) and the Minnesota Living with Heart Failure Questionnaire (MLHFQ). This was performed repeatedly during a study period of one year. <i>Results</i>. Patients with a walking distance lower than median experienced a lower HRQL than the higher performing half of the cohort, in four dimensions of the SF-36 and the summary of physical and mental components, but not in the dimensions of MLHFQ. <i>Conclusion</i>. Patients with heart failure with a short walking distance assessed their quality of life as inferior in half of the dimensions in the SF-36 but not in the dimensions measured with the MLHFQ. Thus, different aspects of the symptomatology are uncovered using the 6MWT and the different HRQL tools.</p>","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40671826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Long-term effects of cardiac rehabilitation after heart valve surgery - results from the randomised CopenHeartVR trial. 心脏瓣膜手术后心脏康复的长期影响——来自随机CopenHeartVR试验的结果
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2095432
Kirstine L Sibilitz, Lars Hermann Tang, Selina Kikkenborg Berg, Lau Caspar Thygesen, Signe Stelling Risom, Trine Bernholdt Rasmussen, Jean-Paul Schmid, Britt Borregaard, Christian Hassager, Lars Køber, Rod S Taylor, Ann-Dorthe Zwisler

Aims. The CopenHeartVR trial found positive effects of cardiac rehabilitation (CR) on physical capacity at 4 months. The long-term effects of CR following valve surgery remains unclear, especially regarding readmission and mortality. Using data from he CopenHeartVR Trial we investigated long-term effects on physical capacity, mental and physical health and effect on mortality and readmission rates as prespecified in the original protocol. Methods. A total of 147 participants were included after heart valve surgery and randomly allocated 1:1 to 12-weeks exercise-based CR including a psycho-educational programme (intervention group) or control. Physical capacity was assessed as peak oxygen uptake (VO2 peak) measured by cardiopulmonary exercise testing, mental and physical health by Short Form-36 questionnaire, Hospital Anxiety and Depression Scale, and HeartQol. Mortality and readmission were obtained from hospital records and registers. Groups were compared using mixed regression model analysis and log rank test. Results. No differences in VO2 peak at 12 months or in self-assessed mental and physical health at 24 months (68% vs 75%, p = .120) was found. However, our data demonstrated reduction in readmissions in the intervention group at intermediate time points; after 3, 6 (43% vs 59%, p = .03), and 12 (53% vs 67%, p = .04) months, respectively, but no significant effect at 24 months. Conclusions. Exercise-based CR after heart valve surgery reduces combined readmissions and mortality up to 12 months despite lack of improvement in exercise capacity, physical and mental health long-term. Exercise-based CR can ensure short-term benefits in terms of physical capacity, and lower readmission within a year, but more research is needed to sustain these effects over a longer time period. These considerations should be included in the management of patients after heart valve surgery.

目标CopenHeartVR试验发现心脏康复(CR)在4个月时对身体能力有积极影响。瓣膜手术后CR的长期影响尚不清楚,特别是关于再入院和死亡率。使用来自CopenHeartVR试验的数据,我们调查了对身体能力、精神和身体健康的长期影响,以及对原始方案中预先规定的死亡率和再入院率的影响。方法。共有147名参与者在心脏瓣膜手术后被纳入,并随机按1:1分配到12周的基于运动的CR,包括心理教育计划(干预组)或对照组。以心肺运动试验测定的摄氧量峰值(VO2峰值)、简表36问卷、医院焦虑抑郁量表和HeartQol评价身心健康状况。死亡率和再入院率从医院记录和登记册中获得。各组间比较采用混合回归模型分析和log rank检验。结果。12个月时的VO2峰值或24个月时自我评估的身心健康状况无差异(68% vs 75%, p = .120)。然而,我们的数据显示干预组在中间时间点的再入院率有所降低;分别在3、6(43%对59%,p = 0.03)和12(53%对67%,p = 0.04)个月后,但在24个月时无显著效果。结论。心脏瓣膜手术后基于运动的CR减少了长达12个月的再入院和死亡率,尽管长期缺乏运动能力、身体和心理健康的改善。基于运动的CR可以确保在体能方面的短期收益,并在一年内降低再入院率,但需要更多的研究来维持这些效果在更长的时间内。这些考虑应包括在心脏瓣膜手术后患者的管理。
{"title":"Long-term effects of cardiac rehabilitation after heart valve surgery - results from the randomised CopenHeart<sub>VR</sub> trial.","authors":"Kirstine L Sibilitz,&nbsp;Lars Hermann Tang,&nbsp;Selina Kikkenborg Berg,&nbsp;Lau Caspar Thygesen,&nbsp;Signe Stelling Risom,&nbsp;Trine Bernholdt Rasmussen,&nbsp;Jean-Paul Schmid,&nbsp;Britt Borregaard,&nbsp;Christian Hassager,&nbsp;Lars Køber,&nbsp;Rod S Taylor,&nbsp;Ann-Dorthe Zwisler","doi":"10.1080/14017431.2022.2095432","DOIUrl":"https://doi.org/10.1080/14017431.2022.2095432","url":null,"abstract":"<p><p><b><i>Aims</i></b>. The CopenHeart<sub>VR</sub> trial found positive effects of cardiac rehabilitation (CR) on physical capacity at 4 months. The long-term effects of CR following valve surgery remains unclear, especially regarding readmission and mortality. Using data from he CopenHeart<sub>VR</sub> Trial we investigated long-term effects on physical capacity, mental and physical health and effect on mortality and readmission rates as prespecified in the original protocol. <b><i>Methods</i>.</b> A total of 147 participants were included after heart valve surgery and randomly allocated 1:1 to 12-weeks exercise-based CR including a psycho-educational programme (intervention group) or control. Physical capacity was assessed as peak oxygen uptake (VO<sub>2</sub> peak) measured by cardiopulmonary exercise testing, mental and physical health by Short Form-36 questionnaire, Hospital Anxiety and Depression Scale, and HeartQol. Mortality and readmission were obtained from hospital records and registers. Groups were compared using mixed regression model analysis and log rank test. <b><i>Results</i>.</b> No differences in VO<sub>2</sub> peak at 12 months or in self-assessed mental and physical health at 24 months (68% vs 75%, <i>p</i> = .120) was found. However, our data demonstrated reduction in readmissions in the intervention group at intermediate time points; after 3, 6 (43% vs 59%, <i>p</i> = .03), and 12 (53% vs 67%, <i>p</i> = .04) months, respectively, but no significant effect at 24 months. <b><i>Conclusions</i></b>. Exercise-based CR after heart valve surgery reduces combined readmissions and mortality up to 12 months despite lack of improvement in exercise capacity, physical and mental health long-term. Exercise-based CR can ensure short-term benefits in terms of physical capacity, and lower readmission within a year, but more research is needed to sustain these effects over a longer time period. These considerations should be included in the management of patients after heart valve surgery.</p>","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40488472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Women with atrial fibrillation undergoing pulmonary vein isolation are more symptomatic but improve more in health-related quality of life and symptom burden than men. 与男性相比,接受肺静脉隔离的房颤女性更有症状,但在健康相关生活质量和症状负担方面改善更多。
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2107235
Carina Carnlöf, Marie Iwarzon, Mats Jensen-Urstad, Fredrik Gadler, Per Insulander

Gender differences in symptoms and perceived health-related quality of life (HRQOL) in patients with atrial fibrillation (AF) referred to pulmonary vein isolation (PVI) have been reported previously. Women experience a lower HRQOL, faster heart rate, and more symptoms such as palpitation and dyspnea than men. Furthermore, they experience worse physical functioning independently of other heart diseases or age. This study evaluates referral patterns and symptoms, morbidity, functional impairment, and HRQOL from a gender perspective in patients with AF before and 6 months after PVI. The study includes 242 patients (121 men), mean age 62 ± 9 years, referred for PVI. Symptoms were assessed with the Symptom Checklist: Frequency and Severity (SCL), HRQOL with Short Form 36 (SF-36), and the functional impairment with Sickness Impact Profile (SIP). The patients' own experiences of the referral process and history of their disease were evaluated with a supplementary questionnaire. The results showed that women improved more than men in HRQOL, SIP, and SCL 6 months post PVI. There were no sex differences in proportion of paroxysmal and persistent AF or ablation outcome. At baseline, women scored higher than men in both scales of the SCL (p < 0.001), scored lower in all components in SF-36, and scored higher in five categories of the SIP. Women were not more reluctant to accept referral for ablation when offered. The conclusion is that women with AF undergoing PVI are more symptomatic but also improve more in HRQOL and in symptom burden than men.

以前有报道过肺静脉隔离(PVI)心房颤动(AF)患者的症状和感知的健康相关生活质量(HRQOL)的性别差异。与男性相比,女性的HRQOL更低,心率更快,心悸和呼吸困难等症状更多。此外,他们的身体机能更差,与其他心脏疾病或年龄无关。本研究从性别角度评估房颤患者在PVI前后6个月的转诊模式、症状、发病率、功能损害和HRQOL。本研究纳入242例患者(男性121例),平均年龄62±9岁。使用症状检查表评估症状:频率和严重程度(SCL), HRQOL (SF-36)和疾病影响特征(SIP)的功能损害。患者自身的转诊过程和病史通过补充问卷进行评估。结果显示,在PVI后6个月,女性在HRQOL、SIP和SCL方面的改善高于男性。阵发性和持续性房颤或消融结果的比例没有性别差异。在基线时,女性在两种SCL量表上的得分都高于男性(p
{"title":"Women with atrial fibrillation undergoing pulmonary vein isolation are more symptomatic but improve more in health-related quality of life and symptom burden than men.","authors":"Carina Carnlöf,&nbsp;Marie Iwarzon,&nbsp;Mats Jensen-Urstad,&nbsp;Fredrik Gadler,&nbsp;Per Insulander","doi":"10.1080/14017431.2022.2107235","DOIUrl":"https://doi.org/10.1080/14017431.2022.2107235","url":null,"abstract":"<p><p>Gender differences in symptoms and perceived health-related quality of life (HRQOL) in patients with atrial fibrillation (AF) referred to pulmonary vein isolation (PVI) have been reported previously. Women experience a lower HRQOL, faster heart rate, and more symptoms such as palpitation and dyspnea than men. Furthermore, they experience worse physical functioning independently of other heart diseases or age. This study evaluates referral patterns and symptoms, morbidity, functional impairment, and HRQOL from a gender perspective in patients with AF before and 6 months after PVI. The study includes 242 patients (121 men), mean age 62 ± 9 years, referred for PVI. Symptoms were assessed with the Symptom Checklist: Frequency and Severity (SCL), HRQOL with Short Form 36 (SF-36), and the functional impairment with Sickness Impact Profile (SIP). The patients' own experiences of the referral process and history of their disease were evaluated with a supplementary questionnaire. The results showed that women improved more than men in HRQOL, SIP, and SCL 6 months post PVI. There were no sex differences in proportion of paroxysmal and persistent AF or ablation outcome. At baseline, women scored higher than men in both scales of the SCL (<i>p</i> < 0.001), scored lower in all components in SF-36, and scored higher in five categories of the SIP. Women were not more reluctant to accept referral for ablation when offered. The conclusion is that women with AF undergoing PVI are more symptomatic but also improve more in HRQOL and in symptom burden than men.</p>","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40595633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Fast acquisition of left and right ventricular function parameters applying cardiovascular magnetic resonance in clinical routine - validation of a 2-shot compressed sensing cine sequence. 应用心血管磁共振快速获取左、右心室功能参数在2次压缩传感序列临床常规验证中的应用。
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2099010
Jan Gröschel, Clemens Ammann, Leonora Zange, Darian Viezzer, Christoph Forman, Michaela Schmidt, Edyta Blaszczyk, Jeanette Schulz-Menger

Objectives. To evaluate if cine sequences accelerated by compressed sensing (CS) are feasible in clinical routine and yield equivalent cardiac morphology in less time. Design. We evaluated 155 consecutive patients with various cardiac diseases scanned during our clinical routine. LV and RV short axis (SAX) cine images were acquired by conventional and prototype 2-shot CS sequences on a 1.5 T CMR. The 2-shot prototype captures the entire heart over a period of 3 beats making the acquisition potentially even faster. Both scans were performed with identical slice parameters and positions. We compared LV and RV morphology with Bland-Altmann plots and weighted the results in relation to pre-defined tolerance intervals. Subjective and objective image quality was evaluated using a 4-point score and adapted standardized criteria. Scan times were evaluated for each sequence. Results. In total, no acquisitions were lost due to non-diagnostic image quality in the subjective image score. Objective image quality analysis showed no statistically significant differences. The scan time of the CS cines was significantly shorter (p < .001) with mean scan times of 178 ± 36 s compared to 313 ± 65 s for the conventional cine. All cardiac function parameters showed excellent correlation (r 0.978-0.996). Both sequences were considered equivalent for the assessment of LV and RV morphology. Conclusions. The 2-shot CS SAX cines can be used in clinical routine to acquire cardiac morphology in less time compared to the conventional method, with no total loss of acquisitions due to nondiagnostic quality.

Trial registration: ISRCTN12344380. Registered 20 November 2020, retrospectively registered.

目标。评价压缩感知(CS)加速的影像序列在临床常规中是否可行,并在更短的时间内产生等效的心脏形态。设计。我们评估了155例在我们的临床常规中连续扫描的各种心脏疾病患者。在1.5 T CMR上分别采用常规和原型2次CS序列获取左、右心室短轴(SAX)影像。2次的原型机在3次跳动的时间内捕捉整个心脏,这使得获取速度可能更快。两次扫描均以相同的切片参数和位置进行。我们将左心室和右心室形态学与Bland-Altmann图进行比较,并将结果与预定义的耐受区间进行加权。主观和客观图像质量采用4分评分和适应的标准化标准进行评估。评估每个序列的扫描时间。结果。总的来说,由于主观图像评分中的非诊断图像质量,没有捕获丢失。客观图像质量分析差异无统计学意义。CS扫描时间明显缩短(p r 0.978 ~ 0.996)。对于左室和右室形态的评估,这两个序列被认为是等效的。结论。与传统方法相比,2次CS SAX扫描可用于临床常规,在更短的时间内获得心脏形态,并且不会因非诊断质量而导致获取的全部损失。试验注册:ISRCTN12344380。注册于2020年11月20日,回顾性注册。
{"title":"Fast acquisition of left and right ventricular function parameters applying cardiovascular magnetic resonance in clinical routine - validation of a 2-shot compressed sensing cine sequence.","authors":"Jan Gröschel,&nbsp;Clemens Ammann,&nbsp;Leonora Zange,&nbsp;Darian Viezzer,&nbsp;Christoph Forman,&nbsp;Michaela Schmidt,&nbsp;Edyta Blaszczyk,&nbsp;Jeanette Schulz-Menger","doi":"10.1080/14017431.2022.2099010","DOIUrl":"https://doi.org/10.1080/14017431.2022.2099010","url":null,"abstract":"<p><p><i>Objectives.</i> To evaluate if cine sequences accelerated by compressed sensing (CS) are feasible in clinical routine and yield equivalent cardiac morphology in less time. <i>Design.</i> We evaluated 155 consecutive patients with various cardiac diseases scanned during our clinical routine. LV and RV short axis (SAX) cine images were acquired by conventional and prototype 2-shot CS sequences on a 1.5 T CMR. The 2-shot prototype captures the entire heart over a period of 3 beats making the acquisition potentially even faster. Both scans were performed with identical slice parameters and positions. We compared LV and RV morphology with Bland-Altmann plots and weighted the results in relation to pre-defined tolerance intervals. Subjective and objective image quality was evaluated using a 4-point score and adapted standardized criteria. Scan times were evaluated for each sequence. <i>Results.</i> In total, no acquisitions were lost due to non-diagnostic image quality in the subjective image score. Objective image quality analysis showed no statistically significant differences. The scan time of the CS cines was significantly shorter (<i>p</i> < .001) with mean scan times of 178 ± 36 s compared to 313 ± 65 s for the conventional cine. All cardiac function parameters showed excellent correlation (<i>r</i> 0.978-0.996). Both sequences were considered equivalent for the assessment of LV and RV morphology. <i>Conclusions.</i> The 2-shot CS SAX cines can be used in clinical routine to acquire cardiac morphology in less time compared to the conventional method, with no total loss of acquisitions due to nondiagnostic quality.</p><p><strong>Trial registration: </strong>ISRCTN12344380. Registered 20 November 2020, retrospectively registered.</p>","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40506686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Expanding the evidence base of new cardiovascular treatments by systematic registry-based evaluation of their implementation in clinical practice. 通过对心血管新疗法在临床实践中的实施进行系统登记评估,扩大其证据基础。
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/14017431.2022.2100474
Björn Redfors, Elmir Omerovic
Health care resources are limited. It is therefore important to distinguish cost-effective and life-saving new treatments from costly but ineffective treatments, or costly treatments that are no more effective than less expensive alternatives. Unfortunately, few new treatments are systematically evaluated after they are implemented in clinical practice. We advocate for systematic large-scale evaluation of the efficacy and safety of new treatments when they are introduced in clinical practice; by pragmatic, cluster-randomized implementation strategies followed up through health care registries. Randomized controlled trials (RCTs) represent robust and important tools for assuring that a new treatment is efficacious and safe prior to its implementation in clinical care, but even well-conducted RCTs rarely fully establish the efficacy and safety of treatment across different subsets of patients [1]. Furthermore, the RCTs that form the evidence base for the implementation of new treatments are often funded and conducted by profit-seeking organizations, a fact that arguably further justifies the continued evaluation of the performance of these treatments. Despite persisting uncertainties in their efficacy and safety at the time of their implementation in clinical practice, few treatments are systematically evaluated after their implementation [2]. Several treatments that were found to be inefficacious compared to less expensive alternatives many years after they were implemented could have been identified as ineffective earlier if they had been systematically evaluated when they were implemented [3]. Once a new treatment has been shown to be efficacious and safe in a traditional RCT, healthcare registries can be used as data capture systems to allow inexpensive further evaluation of the efficacy and safety of new treatments if the implementation of the treatment is done systematically using a cluster-randomized approach [4]. Cluster randomized designs represent flexible means of systematically implementing new treatments, by randomizing individual hospitals or health care regions (clusters of patients) to different treatments (parallel group design) or to the order in which they implement a new treatment (stepped wedge design) [5]. To reliably evaluate the implementation of a new treatment in a health care registry, the registry must be of sufficient detail and quality to allow for identification of the desired study population and reliable endpoint ascertainment. Some contemporary health care registries, such as the nationwide Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART), fulfill these criteria [4]. By systematically introducing new treatments using a cluster randomized approach and following up outcomes in already existing health registries, data can be acquired for a substantial number of patients at minimal cost. Clusterrandomized implementation
{"title":"Expanding the evidence base of new cardiovascular treatments by systematic registry-based evaluation of their implementation in clinical practice.","authors":"Björn Redfors,&nbsp;Elmir Omerovic","doi":"10.1080/14017431.2022.2100474","DOIUrl":"https://doi.org/10.1080/14017431.2022.2100474","url":null,"abstract":"Health care resources are limited. It is therefore important to distinguish cost-effective and life-saving new treatments from costly but ineffective treatments, or costly treatments that are no more effective than less expensive alternatives. Unfortunately, few new treatments are systematically evaluated after they are implemented in clinical practice. We advocate for systematic large-scale evaluation of the efficacy and safety of new treatments when they are introduced in clinical practice; by pragmatic, cluster-randomized implementation strategies followed up through health care registries. Randomized controlled trials (RCTs) represent robust and important tools for assuring that a new treatment is efficacious and safe prior to its implementation in clinical care, but even well-conducted RCTs rarely fully establish the efficacy and safety of treatment across different subsets of patients [1]. Furthermore, the RCTs that form the evidence base for the implementation of new treatments are often funded and conducted by profit-seeking organizations, a fact that arguably further justifies the continued evaluation of the performance of these treatments. Despite persisting uncertainties in their efficacy and safety at the time of their implementation in clinical practice, few treatments are systematically evaluated after their implementation [2]. Several treatments that were found to be inefficacious compared to less expensive alternatives many years after they were implemented could have been identified as ineffective earlier if they had been systematically evaluated when they were implemented [3]. Once a new treatment has been shown to be efficacious and safe in a traditional RCT, healthcare registries can be used as data capture systems to allow inexpensive further evaluation of the efficacy and safety of new treatments if the implementation of the treatment is done systematically using a cluster-randomized approach [4]. Cluster randomized designs represent flexible means of systematically implementing new treatments, by randomizing individual hospitals or health care regions (clusters of patients) to different treatments (parallel group design) or to the order in which they implement a new treatment (stepped wedge design) [5]. To reliably evaluate the implementation of a new treatment in a health care registry, the registry must be of sufficient detail and quality to allow for identification of the desired study population and reliable endpoint ascertainment. Some contemporary health care registries, such as the nationwide Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART), fulfill these criteria [4]. By systematically introducing new treatments using a cluster randomized approach and following up outcomes in already existing health registries, data can be acquired for a substantial number of patients at minimal cost. Clusterrandomized implementation ","PeriodicalId":21383,"journal":{"name":"Scandinavian Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40529886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Scandinavian Cardiovascular Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1